FdaApplication
ANDA 210911
Identifiers
- fda_app_no: ANDA210911
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS PHARMS USA INC |
| application_type | ANDA |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 23.75MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 145MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 95MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 245MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 195MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 48.75MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 61.25MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA; LEODOPA | CARBIDOPA; LEODOPA | 36.25MG | CAPSULE, EXTENDED RELEASE |
8 products